Magnolia Bark (Magnolia officinalis)

Magnolia bark extract contains the bioactive lignans honokiol and magnolol, used in traditional Chinese medicine for anxiety and stress. RCT (n=56, 4 weeks): Relora (magnolia+phellodendron) reduced salivary cortisol by 18% and improved mood parameters including stress (-11%), tension (-13%), depression (-20%), anger (-42%), and fatigue (-31%) vs placebo. Pilot RCT in women: Reduced transitory anxiety on Spielberger STATE questionnaire. Honokiol and magnolol are positive allosteric modulators of GABAA receptors, enhancing both synaptic and extra-synaptic inhibitory transmission. Anxiolytic effects comparable to diazepam without sedation, motor dysfunction, or amnesia in animal models.

Quick Answer

What it is

Magnolia bark extract contains the bioactive lignans honokiol and magnolol, used in traditional Chinese medicine for anxiety and stress. RCT (n=56, 4 weeks): Relora (magnolia+phellodendron) reduced salivary cortisol by 18% and improved mood parameters including stress (-11%), tension (-13%), depression (-20%), anger (-42%), and fatigue (-31%) vs placebo.

Key findings

  • Grade B: Cortisol Reduction (Stress)
  • Grade B: Mood and Stress Parameters (Mental Health)
  • Grade B: Anxiety Reduction (Mental Health)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts: Magnolia Bark (Magnolia officinalis)

Quick Facts: Magnolia Bark (Magnolia officinalis)

  • Best Evidence:Grade B
  • Conditions Studied:5
  • Research Outcomes:6
  • Grade B Findings:3
  • Key Effect:Stress
Outcomes by grade:
A0
B3
C3
D0
5 conditions · 6 outcomes

Detailed Outcomes

|
B
Cortisol Reduction
RCT (n=56, 4 weeks): Relora (magnolia+phellodendron 250mg 3x/day) reduced salivary cortisol exposure by 18% (p<0.05) vs placebo in moderately stressed subjects. Evening cortisol levels particularly reduced.
moderateImproves
B
Mood and Stress Parameters
RCT (n=56, 4 weeks): Relora significantly improved mood state parameters vs placebo: Overall Stress (-11%), Tension (-13%), Depression (-20%), Anger (-42%), Fatigue (-31%), Confusion (-27%), Global Mood State (+11%), and Vigor (+18%).
moderateImproves
B
Anxiety Reduction
Pilot RCT (n=40 women, 6 weeks): Relora reduced temporary, transitory anxiety on Spielberger STATE anxiety questionnaire vs placebo. Animal studies: Honokiol (0.2 mg/kg) showed anxiolytic effects comparable to diazepam 1 mg/kg without motor dysfunction or sedation.
moderateImproves
C
Weight Management
Pilot RCT (n=28 women, 6 weeks): Placebo group gained significant weight (+1.5 kg, p<0.01), while magnolia+phellodendron group showed no weight change. Marginally significant reduction in evening cortisol (p=0.06) in treatment group.
smallImproves
C
Sleep Quality
Preclinical: Honokiol (10-20 mg/kg) shortened sleep latency to NREM sleep and increased NREM sleep amount by modulating GABAA benzodiazepine site. Clinical evidence limited but mechanism supports sleep promotion without next-day sedation.
moderateImproves
C
Neuroprotection (Preclinical)
Preclinical studies: Honokiol and magnolol prevented age-related memory deficits in senescence-accelerated mice. Decreased β-amyloid induced neuronal death through reduced ROS, calcium, and caspase-3 inhibition. Preserved cholinergic neurons via Akt pathway activation.
moderateImproves

Research Citations (10)

Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint
(2023)
PMID: 37940681
Honokiol-Rich Magnolia officinalis Bark Extract Attenuates Trauma-Induced Neuropathic Pain
(2023)
PMID: 37629145
A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 receptor
(2021)
PMID: 33950239
Effect of Magnolia officinalis and Phellodendron amurense (Relora®) on cortisol and psychological mood state in moderately stressed subjects
(2013)
PMID: 23924268
Neuro-modulating effects of honokiol: a review
(2013)
PMID: 24012603
The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors
(2012)
PMID: 22445602
Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABA(A) receptor in mice
(2012)
PMID: 22796355
Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial
(2008)
PMID: 18426577
Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial
(2006)
PMID: 16454147
Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam-like side-effects in mice
(1999)
PMID: 10197425

Related Supplements

Probiotics

2 shared conditions · 215 outcomes

Probiotics are microorganisms that can have a positive effect on health.

Melatonin

2 shared conditions · 141 outcomes

Melatonin is a hormone secreted in the brain that regulates sleep. It appears to be highly sensitive to light therapy and dark therapy. Oral ingestion of melatonin may be used as a sleep aid. It is non-addictive.

Magnesium

2 shared conditions · 248 outcomes

Magnesium is an essential dietary mineral that is involved in energy production, nervous system function, blood pressure regulation, and blood glucose control. A lack of magnesium in the diet — which is common in modern societies — is associated with an increased risk of diabetes, cardiovascular disease, and other health conditions.

Luteolin

2 shared conditions · 6 outcomes

Luteolin is a flavone found in celery, parsley, broccoli, chamomile, and peppers. It exhibits potent anti-inflammatory, neuroprotective, and mast cell-stabilizing properties. Open-label pilot study (n=50, 26 weeks): Luteolin formulation significantly improved adaptive functioning in children with ASD (P<0.005) with 26.6-34.8% reduction in Aberrant Behavior Checklist scores. Meta-analysis (n=441): PEA+luteolin combination improved post-COVID olfactory dysfunction. More potent than cromolyn at inhibiting mast cell mediator release (histamine, tryptase, IL-6, TNF). Preclinical evidence supports neuroprotective effects in AD, PD, and TBI models via NF-κB inhibition and Nrf2 activation.

GABA

2 shared conditions · 7 outcomes

GABA is the main inhibitory neurotransmitter in the brain. Oral GABA supplements show modest benefits for sleep onset and anxiety in small trials. CRITICAL ISSUE: Oral GABA probably does NOT cross the blood-brain barrier significantly - studies conflict but most suggest very poor BBB penetration. Effects may occur via gut-brain axis, enteric nervous system, or vagus nerve signaling rather than direct brain action. Safe even at high doses but mechanism of any CNS effects is unclear.